Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer
- 1 June 2002
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 186 (6) , 1167-1173
- https://doi.org/10.1067/mob.2002.123820
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaNew England Journal of Medicine, 1999
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervixCancer, 1997
- Phase II Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced/Recurrent Carcinoma of the Uterine Cervix and VaginaGynecologic Oncology, 1995
- Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update for a nonrandomized comparisonInternational Journal of Radiation Oncology*Biology*Physics, 1995
- The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a reviewInternational Journal of Gynecologic Cancer, 1993